Micron enters into collaboration with top-5 pharmaceutical company

ATLANTA, December 1, 2016 – Micron Biomedical’s Vice President, R&D, Devin McAllister, PhD,  announces the signing of a research agreement between Micron and a leading global pharmaceutical company.  Under the research agreement, Micron will develop a novel microneedle patch concept to be evaluated in pre-clinical studies. The terms of the collaboration are confidential.